trending Market Intelligence /marketintelligence/en/news-insights/trending/9lqauqs4kayh-tjosqypww2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

ImpediMed sells test, measurement business for $500,000

Virtual Multichannel Carriage: Sports Networks

An interview with Antony Jenkins, Founder & Executive Chairman, 10x Future Technologies

An interview with Nicolas Veron, Economist, Senior Fellow at Bruegel

An interview with Dan Frumkin, CEO, Metro Bank


ImpediMed sells test, measurement business for $500,000

ImpediMed Ltd. sold Xitron Technologies Inc. to Vitrek LLC for $500,000, subject to working capital adjustment.

Under the agreement, Vitrek acquired the test and measurement business' net assets, while ImpediMed acquired a perpetual worldwide license for all technology and know-how related to Xitron Technologies' medical segment.

"We are very pleased to have completed this transaction so that we can fully focus the organization on the opportunities we have with our SOZO digital health platform," ImpediMed Managing Director and CEO Richard Carreon said in a news release.

Australia-based ImpediMed makes and markets bioimpedance instruments, consumables and software.